Published in Adv Neurol on January 01, 2003
Network modulation in the treatment of Parkinson's disease. Brain (2006) 2.52
Changes in network activity with the progression of Parkinson's disease. Brain (2007) 2.46
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab (2006) 2.42
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.98
Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage (2006) 1.92
Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci (2008) 1.56
Abnormal regional brain function in Parkinson's disease: truth or fiction? Neuroimage (2008) 1.12
Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease. Mov Disord (2009) 0.79
Assessment of disease progression in parkinsonism. J Neurol (2004) 0.76
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet (2007) 7.01
Network modulation in the treatment of Parkinson's disease. Brain (2006) 2.52
Changes in network activity with the progression of Parkinson's disease. Brain (2007) 2.46
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab (2006) 2.42
Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci (2009) 2.01
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.98
Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage (2006) 1.92
Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage (2006) 1.84
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput (2005) 1.78
Differential cortical and subcortical activations in learning rotations and gains for reaching: a PET study. J Neurophysiol (2003) 1.71
Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol (2003) 1.63
Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci (2008) 1.56
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol (2010) 1.56
The differential effect of PD and normal aging on early explicit sequence learning. Neurology (2003) 1.52
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci (2010) 1.50
Learning and consolidation of visuo-motor adaptation in Parkinson's disease. Parkinsonism Relat Disord (2008) 1.44
Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues. Neuroimage (2010) 1.43
Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery. Report of 2 cases. J Neurosurg (2011) 1.43
Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol (2007) 1.42
Abnormal metabolic networks in atypical parkinsonism. Mov Disord (2008) 1.39
Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol (2002) 1.39
Microstructural white matter changes in primary torsion dystonia. Mov Disord (2008) 1.38
Preclinical Huntington's disease: compensatory brain responses during learning. Ann Neurol (2006) 1.36
Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage (2010) 1.36
Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage (2009) 1.36
Primary dystonia: is abnormal functional brain architecture linked to genotype? Ann Neurol (2002) 1.35
Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging. Neurobiol Dis (2010) 1.34
Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc Natl Acad Sci U S A (2011) 1.33
Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study. Brain (2007) 1.33
Metabolic brain networks in translational neurology: concepts and applications. Ann Neurol (2012) 1.32
Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner. Clin Positron Imaging (1998) 1.31
Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. J Nucl Med (2002) 1.31
Imaging essential tremor. Mov Disord (2010) 1.27
Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp (2004) 1.26
Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. J Cereb Blood Flow Metab (2006) 1.26
Microstructural white matter changes in carriers of the DYT1 gene mutation. Ann Neurol (2004) 1.24
Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain (2008) 1.24
Quantification of Parkinson's disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging (2006) 1.24
Learning networks in health and Parkinson's disease: reproducibility and treatment effects. Hum Brain Mapp (2003) 1.23
Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology (2004) 1.21
Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage (2004) 1.21
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J Nucl Med (2009) 1.20
The impact of inaccurate Internet health information in a secondary school learning environment. J Med Internet Res (2008) 1.20
Neuroimaging and therapeutics in movement disorders. NeuroRx (2005) 1.17
Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study. Brain (2010) 1.16
The metabolic topography of posthypoxic myoclonus. Neurology (2004) 1.16
The functional neuroanatomy of geriatric depression. Int J Geriatr Psychiatry (2009) 1.16
An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol (2006) 1.15
Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage (2011) 1.15
Dopaminergic suppression of brain deactivation responses during sequence learning. J Neurosci (2008) 1.15
The metabolic pathology of dopa-responsive dystonia. Ann Neurol (2005) 1.14
Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab (2010) 1.14
Abnormal regional brain function in Parkinson's disease: truth or fiction? Neuroimage (2008) 1.12
A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health (2004) 1.12
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord (2002) 1.12
Micronutrient status in children with IBD: true deficiencies or epiphenomenon of the systemic inflammatory response. J Pediatr Gastroenterol Nutr (2013) 1.09
L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease. Parkinsonism Relat Disord (2006) 1.08
Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry (2002) 1.06
Isolation and identification of novel microcystin-degrading bacteria. Appl Environ Microbiol (2009) 1.06
Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cogn Behav Neurol (2007) 1.06
Implementing a seventh grade vaccination law: school factors associated with completion of required immunizations. Prev Med (2003) 1.05
Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease. Mol Imaging Biol (2007) 1.03
Network biomarkers for the diagnosis and treatment of movement disorders. Neurobiol Dis (2008) 1.02
Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology (Berl) (2008) 1.02
Functional imaging of sequence learning in Parkinson's disease. J Neurol Sci (2006) 1.01
Patient and public involvement in the coproduction of knowledge: reflection on the analysis of qualitative data in a mental health study. Qual Health Res (2012) 1.00
Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study. Neuroimage (2006) 1.00
Early Parkinson's disease: longitudinal changes in brain activity during sequence learning. Neurobiol Dis (2009) 1.00
Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism. J Cereb Blood Flow Metab (2011) 0.99
Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. Am J Geriatr Psychiatry (2002) 0.99
Metabolic changes in DYT11 myoclonus-dystonia. Neurology (2013) 0.98
The barriers to and enablers of providing reasonably adjusted health services to people with intellectual disabilities in acute hospitals: evidence from a mixed-methods study. BMJ Open (2014) 0.98
Identification of disease-related spatial covariance patterns using neuroimaging data. J Vis Exp (2013) 0.98
Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects. J Nucl Med (2003) 0.98
Metabolic network as a progression biomarker of premanifest Huntington's disease. J Clin Invest (2013) 0.95
Introducing peer worker roles into UK mental health service teams: a qualitative analysis of the organisational benefits and challenges. BMC Health Serv Res (2013) 0.95
Impaired sequence learning in dystonia mutation carriers: a genotypic effect. Brain (2011) 0.95
Evolving metabolic changes during the first postoperative year after subthalamotomy. J Neurosurg (2003) 0.95
Changes in faecal microbiota of infants with cow's milk protein allergy--a Spanish prospective case-control 6-month follow-up study. Pediatr Allergy Immunol (2009) 0.94
Serotonin modulation of cerebral glucose metabolism in depressed older adults. Biol Psychiatry (2009) 0.94
Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics. Neuroimage (2004) 0.93
Neuroimaging in human dystonia. J Med Invest (2005) 0.93
Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiol Aging (2004) 0.93
Parkinson's disease: increased motor network activity in the absence of movement. J Neurosci (2013) 0.93
Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners. Hum Brain Mapp (2013) 0.92
Early stage Parkinson's disease patients and normal volunteers: comparative mechanisms of sequence learning. Hum Brain Mapp (2003) 0.92
Pallidal stimulation for parkinsonism: improved brain activation during sequence learning. Ann Neurol (2002) 0.92
Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT. Neurobiol Aging (2006) 0.92
Functional brain networks in movement disorders: recent advances. Curr Opin Neurol (2012) 0.92
Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. Brain (2009) 0.91
Abnormal metabolic network activity in REM sleep behavior disorder. Neurology (2014) 0.91
Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging. Mov Disord (2007) 0.91
Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression. Hum Brain Mapp (2010) 0.91
Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Mol Cancer Ther (2007) 0.91